Modulating Toll-like receptor mediated signaling by (1→3)-β-D- glucan rapidly induces cardioprotection

Cardiovascular Research

Volumn 61, Issue 3, 2004, Pages 538-547

  Li, Chuanfu ^a,b   Ha, Tuanzhu ^a   Kelley, Jim ^a   Gao, Xiang ^b   Qiu, Yufeng ^a   Kao, Race L ^a   Browder, William ^a   Williams, David L ^a  

^a East Tennessee State University   (United States)

^b NANJING UNIVERSITY   (China)

Author keywords

Infarction; Ischemia; Rat; Receptors; Signaling transduction

Indexed keywords

GLUCAN PHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATE; TOLL LIKE RECEPTOR; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BETA-GLUCANS; CARDIOTONIC AGENTS; GLUCANS; MALE; MEMBRANE GLYCOPROTEINS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 1142309739     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2003.09.007     Document Type: Article

References (36)

1. Kapadia S., Dibbs Z., Kurrelmeyer K.et al. The role of cytokines in the failing human heart. Cardiol. Clin. 16:1998;645-656.
2. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
3. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature. 406:2000;782-787.
4. Baeuerle P.A., Baltimore D. NF-kB: ten years after. Cell. 87:1996;13-20.
5. Baldwin A.S. Jr. The NF-kappa B and I-kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-683.
6. Altavilla D., Deodato B., Campo G.M.et al. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-κB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 47:2000;515-528.
7. Li C., Browder W., Kao R.L. Early activation of transcription factor NF-κB during ischemia in perfused rat heart. Am. J. Physiol. 276:1999;H543-H552.
8. Li C., Ha T., Liu L., Browder W., Kao R.L. Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart. Surgery. 127:2000;161-169.
9. Li C., Kao R.L., Ha T., Kelley J., Browder I.W., Williams D.L. Early activation of IKKβ during in vivo myocardial ischemia. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H1264-H1271.
10. Morishita R., Sugimoto T., Aoki M.et al. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat. Med. 3:1997;894-899.
11. Thourani V.H., Brar S.S., Kennedy T.P.et al. Nonanticoagulant heparin inhibits NF-kB activation and attenuates myocardial reperfusion injury. Am. J. Physiol. 48:2000;H2084-H2093.
12. Frantz S., Kobzik L., Kim Y.D.et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104:1999;271-280.
13. Edfeldt K., Swedenborg J., Hansson G.K., Yan Z. Expression of toll-like receptors in human atherosclerotic lesions. Circulation. 105:2002;1158-1161.
14. Baumgarten G., Knuefermann P., Nozaki N., Sivasubramanian N., Mann D.L., Vallejo J.G. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J. Infect. Dis. 183:2001;1617-1624.
15. Nemoto S., Vallejo J.G., Kneufermann P.et al. Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart. Am. J. Physiol. Heart Circ. Physiol. 282:2002;H2316-H2323.
16. de Kleijn D., Pasterkamp G. Toll-like receptors in cardiovascular diseases. Cardiovasc. Res. 60:2003;58-67.
17. Fujio Y., Nguyen T., Wencker D., Kitsis R.N., Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 101:2000;660-667.
18. Matsui T., Tao J., del Monte F.et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation. 104:2001;330-335.
19. Arbibe L., Mira J.-P., Teusch N.et al. Toll-like receptor 2-mediated NF-κB activation requires a RAC I-dependent pathway. Nat. Immunol. 1:2000;533-540.
20. Ojaniemi M., Glumoff V., Harju K., Liljeroos M., Vuori K., Hallman M. Phosphatidylinositol 3-kinase is involved in toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33:2003;597-605.
21. Marmiroli S., Bavelloni A., Faenza I.et al. Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. FEBS Lett. 438:1998;49-54.
22. Brown J.M., Grosso M.A., Terada L.S., Whitman G.J.R. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2516-2520.
23. Zacharowski K., Frank S., Otto M.et al. Lipoteichoic acid induces delayed protection in the rat heart, a comparison with endotoxin. Arterioscler. Thromb. Vasc. Biol. 20:2000;1521-1528.
24. Williams D.L., McNamee R.B., Jones E.L.et al. A method for the solubilization of a (1-3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr. Res. 219:1991;203-213.
25. Williams D.L., Ha T., Li C., Kalbfleisch J.H., Laffan J.J., Ferguson D.A. Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery. 126:1999;54-65.
26. Williams D.L., Ha T., Li C., Laffan J., Kalbfleisch J., Browder W. Inhibition of LPS induced NFκB activation by a glucan ligand involves down regulation of IKKβ kinase activity and altered phosphorylation and degradation of Ikβα Shock. 13:2000;446-452.
27. Williams D.L., Mueller A., Browder W. Preclinical and clinical evaluation of carbohydrate immunopharmaceuticals in the prevention of sepsis and septic sequelae. J. Endotoxin Res. 2:1995;203-208.
28. Lowman D., Ensley H., Williams D. Identification of phosphate substitution sites by NMR spectroscopy in a water-soluble phosphorylated (1-3)-β-D-glucan. Carbohydr. Res. 306:1998;559-562.
29. Vivaldt M.T., Kloner R.A., Schoen F.J. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am. J. Pathol. 121:1985;522-530.
30. Herskowitz A., Choi S., Ansari A.A., Wesselingh S. Cytokine mRNA expression in postischemic/reperfusion myocardium. Am. J. Pathol. 146:1995;419-428.
31. Wong S.C., Fukuchi M., Melnyk P., Rodger I., Giaid A. Induction of cyclo oxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive failure. Circulation. 98:1998;100-103.
32. Niebauer J., Volk H.D., Kemp M.et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 353:1999;1838-1842.
33. Frantz S., Kelly R.A., Bourcier T. Role of TLR-2 in the activation of nuclear factor-kappa B by oxidative stress in cardiac myocytes. J. Biol. Chem. 276:2001;5197-5203.
34. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S.J., Gordon S. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197:2003;1119-1124.
35. Hiller G., Sternby M., Sundler R., Wijkander J. Phosphatidylinositol 3-kinase in zymosan- and bacteria-induced signalling to mobilisation of arachidonic acid in macrophages. Biochim. Biophys. Acta. 1485:2000;163-172.
36. Guha M., Mackman N. The PI3K-Akt pathway limits LPS activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277:2002;32124-32132.